Indomethacin-induced gut damage in a surrogate insect model, Galleria mellonella.
Helena EmeryRichard JohnstonAndrew F RowleyChristopher J CoatesPublished in: Archives of toxicology (2019)
Indomethacin is a non-steroidal anti-inflammatory drug that causes gastric ulceration and increased 'leakiness' in rat models, and is used routinely as a toxicology assay to screen novel compounds for repair and restitution properties. We set out to establish conditions for indomethacin-induced gut damage in wax-moth (Galleria mellonella) larvae with a view to reducing the need for rodents in such experimentation. We administered indomethacin (0.5-7.5 µg/larva; 2-30 mg/kg) to G. mellonella via intrahaemocoelic injection and gavage (force-feeding) and monitored survival and development, blood cell (haemocyte) numbers, and changes in gut permeability. Increased levels of gut leakiness were observed within the first 4- to 24 h by tracking fluorescent microspheres in the faeces and haemolymph (blood equivalent). Additionally, we recorded varying levels of tissue damage in histological sections of the insect midgut, including epithelial sloughing and cell necrosis. Degeneration of the midgut was accompanied by significant increases in detoxification-associated activities (superoxide dismutase and glutathione-S-transferase). Herein, we present the first evidence that G. mellonella larvae force-fed indomethacin display broad symptoms of gastric damage similar to their rodent counterparts.
Keyphrases
- aedes aegypti
- oxidative stress
- diabetic rats
- high glucose
- single cell
- zika virus
- anti inflammatory
- high throughput
- cell therapy
- drug induced
- quantum dots
- physical activity
- ultrasound guided
- stem cells
- depressive symptoms
- anti inflammatory drugs
- stress induced
- living cells
- molecularly imprinted
- simultaneous determination
- label free
- fluorescent probe